Overview

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a new blood test as a way to follow the effect of Zometa in treating bone metastases due to lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center
University of Louisville
Collaborators:
James Graham Brown Cancer Center
Novartis Pharmaceuticals
University of Louisville
Treatments:
Diphosphonates
Zoledronic Acid